Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Total 13F shares
-
31,686,396
-
Share change
-
+534,148
-
Total reported value
-
$446,704,897
-
Price per share
-
$14.10
-
Number of holders
-
99
-
Value change
-
+$7,166,136
-
Number of buys
-
49
-
Number of sells
-
50
Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q1 2022
As of 31 Mar 2022,
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,686,396 shares.
The largest 10 holders included
Essex Woodlands Management, Inc., Juniper Investment Company, LLC, ROYCE & ASSOCIATES LP, BlackRock Inc., SV Health Investors, LLC, NUANCE INVESTMENTS, LLC, Redmile Group, LLC, VANGUARD GROUP INC, First Light Asset Management, LLC, and Tamarack Advisers, LP.
This page lists
99
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.